nodes	percent_of_prediction	percent_of_DWPC	metapath
Dapagliflozin—SLC5A4—Metabolism—AQP1—salivary gland cancer	0.00344	0.00344	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—ST3GAL4—salivary gland cancer	0.00343	0.00343	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—ST3GAL4—salivary gland cancer	0.00343	0.00343	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—FGF16—salivary gland cancer	0.0034	0.0034	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—NUP62—salivary gland cancer	0.00326	0.00326	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—VCAN—salivary gland cancer	0.00323	0.00323	CbGpPWpGaD
Dapagliflozin—CYP3A4—Constitutive Androstane Receptor Pathway—SMC1A—salivary gland cancer	0.00314	0.00314	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—DTX4—salivary gland cancer	0.00311	0.00311	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—DTX4—salivary gland cancer	0.00311	0.00311	CbGpPWpGaD
Dapagliflozin—SLC5A11—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	0.00309	0.00309	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—MARCKS—salivary gland cancer	0.00304	0.00304	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—PHGDH—salivary gland cancer	0.00298	0.00298	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—PHGDH—salivary gland cancer	0.00298	0.00298	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—MAML2—salivary gland cancer	0.00295	0.00295	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—ST3GAL4—salivary gland cancer	0.00287	0.00287	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—ST3GAL4—salivary gland cancer	0.00287	0.00287	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—PYGB—salivary gland cancer	0.00282	0.00282	CbGpPWpGaD
Dapagliflozin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—FOXO3—salivary gland cancer	0.00277	0.00277	CbGpPWpGaD
Dapagliflozin—SLC5A4—Metabolism—NUP62—salivary gland cancer	0.00273	0.00273	CbGpPWpGaD
Dapagliflozin—SLC5A4—Metabolism—VCAN—salivary gland cancer	0.00271	0.00271	CbGpPWpGaD
Dapagliflozin—UGT1A9—Aryl Hydrocarbon Receptor Pathway—EP300—salivary gland cancer	0.00262	0.00262	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—AQP1—salivary gland cancer	0.00261	0.00261	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—AQP1—salivary gland cancer	0.00261	0.00261	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—FGF16—salivary gland cancer	0.00257	0.00257	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—FGF16—salivary gland cancer	0.00257	0.00257	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—JAG1—salivary gland cancer	0.00252	0.00252	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—FGFR4—salivary gland cancer	0.00251	0.00251	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—FBXW7—salivary gland cancer	0.00247	0.00247	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—NUP62—salivary gland cancer	0.00247	0.00247	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—NUP62—salivary gland cancer	0.00247	0.00247	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—VCAN—salivary gland cancer	0.00245	0.00245	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—VCAN—salivary gland cancer	0.00245	0.00245	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—PHGDH—salivary gland cancer	0.0023	0.0023	CbGpPWpGaD
Dapagliflozin—SLC5A4—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	0.00226	0.00226	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—MAML2—salivary gland cancer	0.00224	0.00224	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—MAML2—salivary gland cancer	0.00224	0.00224	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—ST3GAL4—salivary gland cancer	0.00222	0.00222	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—FOXO3—salivary gland cancer	0.00208	0.00208	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—NUP62—salivary gland cancer	0.00207	0.00207	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—NUP62—salivary gland cancer	0.00207	0.00207	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—VCAN—salivary gland cancer	0.00205	0.00205	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—VCAN—salivary gland cancer	0.00205	0.00205	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—AQP1—salivary gland cancer	0.00201	0.00201	CbGpPWpGaD
Dapagliflozin—UGT1A9—PPARA activates gene expression—CREBBP—salivary gland cancer	0.00191	0.00191	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—JAG1—salivary gland cancer	0.00191	0.00191	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—JAG1—salivary gland cancer	0.00191	0.00191	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—FGFR4—salivary gland cancer	0.0019	0.0019	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—FGFR4—salivary gland cancer	0.0019	0.0019	CbGpPWpGaD
Dapagliflozin—CYP2A6—Fluoropyrimidine Activity—TP53—salivary gland cancer	0.00188	0.00188	CbGpPWpGaD
Dapagliflozin—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CREBBP—salivary gland cancer	0.00187	0.00187	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—FBXW7—salivary gland cancer	0.00187	0.00187	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—FBXW7—salivary gland cancer	0.00187	0.00187	CbGpPWpGaD
Dapagliflozin—SLC5A1—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	0.00171	0.00171	CbGpPWpGaD
Dapagliflozin—SLC5A2—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	0.00171	0.00171	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—MAP2K2—salivary gland cancer	0.0017	0.0017	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—ISYNA1—salivary gland cancer	0.0017	0.0017	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—NUP62—salivary gland cancer	0.0016	0.0016	CbGpPWpGaD
Dapagliflozin—ABCB1—Transmembrane transport of small molecules—SLC24A3—salivary gland cancer	0.00159	0.00159	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—VCAN—salivary gland cancer	0.00158	0.00158	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—FOXO3—salivary gland cancer	0.00158	0.00158	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—FOXO3—salivary gland cancer	0.00158	0.00158	CbGpPWpGaD
Dapagliflozin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EP300—salivary gland cancer	0.0015	0.0015	CbGpPWpGaD
Dapagliflozin—CYP1A1—Aryl Hydrocarbon Receptor—EP300—salivary gland cancer	0.0015	0.0015	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—NOTCH1—salivary gland cancer	0.00139	0.00139	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—MARCKS—salivary gland cancer	0.00138	0.00138	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—ISYNA1—salivary gland cancer	0.00138	0.00138	CbGpPWpGaD
Dapagliflozin—ABCB1—HIF-1-alpha transcription factor network—CREBBP—salivary gland cancer	0.00132	0.00132	CbGpPWpGaD
Dapagliflozin—UGT1A9—PPARA activates gene expression—EP300—salivary gland cancer	0.0013	0.0013	CbGpPWpGaD
Dapagliflozin—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—CREBBP—salivary gland cancer	0.00129	0.00129	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—MAP2K2—salivary gland cancer	0.00129	0.00129	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—MAP2K2—salivary gland cancer	0.00129	0.00129	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—PYGB—salivary gland cancer	0.00129	0.00129	CbGpPWpGaD
Dapagliflozin—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—salivary gland cancer	0.00128	0.00128	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—CREBBP—salivary gland cancer	0.00126	0.00126	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—salivary gland cancer	0.00121	0.00121	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—MARCKS—salivary gland cancer	0.00112	0.00112	CbGpPWpGaD
Dapagliflozin—CYP1A1—PPARA activates gene expression—CREBBP—salivary gland cancer	0.0011	0.0011	CbGpPWpGaD
Dapagliflozin—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CREBBP—salivary gland cancer	0.00108	0.00108	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—ISYNA1—salivary gland cancer	0.00106	0.00106	CbGpPWpGaD
Dapagliflozin—SLC5A4—Metabolism—CREBBP—salivary gland cancer	0.00106	0.00106	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—NOTCH1—salivary gland cancer	0.00106	0.00106	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—NOTCH1—salivary gland cancer	0.00106	0.00106	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—PHGDH—salivary gland cancer	0.00105	0.00105	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—PYGB—salivary gland cancer	0.00105	0.00105	CbGpPWpGaD
Dapagliflozin—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—salivary gland cancer	0.00103	0.00103	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—ST3GAL4—salivary gland cancer	0.00101	0.00101	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA1—salivary gland cancer	0.000965	0.000965	CbGpPWpGaD
Dapagliflozin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—salivary gland cancer	0.000959	0.000959	CbGpPWpGaD
Dapagliflozin—CYP1A2—Aryl Hydrocarbon Receptor—EP300—salivary gland cancer	0.000959	0.000959	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—CREBBP—salivary gland cancer	0.000957	0.000957	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—CREBBP—salivary gland cancer	0.000957	0.000957	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—AQP1—salivary gland cancer	0.000916	0.000916	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—PTEN—salivary gland cancer	0.000902	0.000902	CbGpPWpGaD
Dapagliflozin—ABCB1—HIF-1-alpha transcription factor network—EP300—salivary gland cancer	0.0009	0.0009	CbGpPWpGaD
Dapagliflozin—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—salivary gland cancer	0.000879	0.000879	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—MARCKS—salivary gland cancer	0.000867	0.000867	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—EP300—salivary gland cancer	0.00086	0.00086	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—PHGDH—salivary gland cancer	0.000852	0.000852	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—ST3GAL4—salivary gland cancer	0.00082	0.00082	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—PYGB—salivary gland cancer	0.000806	0.000806	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—CREBBP—salivary gland cancer	0.000801	0.000801	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—CREBBP—salivary gland cancer	0.000801	0.000801	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—ISYNA1—salivary gland cancer	0.000792	0.000792	CbGpPWpGaD
Dapagliflozin—SLC5A4—Metabolism—PTEN—salivary gland cancer	0.000755	0.000755	CbGpPWpGaD
Dapagliflozin—CYP1A1—PPARA activates gene expression—EP300—salivary gland cancer	0.000749	0.000749	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—AQP1—salivary gland cancer	0.000745	0.000745	CbGpPWpGaD
Dapagliflozin—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CREBBP—salivary gland cancer	0.000742	0.000742	CbGpPWpGaD
Dapagliflozin—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—salivary gland cancer	0.000733	0.000733	CbGpPWpGaD
Dapagliflozin—ABCB1—Transmembrane transport of small molecules—AQP1—salivary gland cancer	0.000729	0.000729	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—NUP62—salivary gland cancer	0.000727	0.000727	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—VCAN—salivary gland cancer	0.000721	0.000721	CbGpPWpGaD
Dapagliflozin—SLC5A4—Metabolism—EP300—salivary gland cancer	0.00072	0.00072	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—PTEN—salivary gland cancer	0.000683	0.000683	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—PTEN—salivary gland cancer	0.000683	0.000683	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—PHGDH—salivary gland cancer	0.000657	0.000657	CbGpPWpGaD
Dapagliflozin—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—salivary gland cancer	0.000656	0.000656	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—EP300—salivary gland cancer	0.000652	0.000652	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—EP300—salivary gland cancer	0.000652	0.000652	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—salivary gland cancer	0.00065	0.00065	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—MARCKS—salivary gland cancer	0.000646	0.000646	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—PIK3CA—salivary gland cancer	0.000636	0.000636	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—ISYNA1—salivary gland cancer	0.000633	0.000633	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—ST3GAL4—salivary gland cancer	0.000632	0.000632	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—CREBBP—salivary gland cancer	0.000619	0.000619	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—PYGB—salivary gland cancer	0.0006	0.0006	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—ISYNA1—salivary gland cancer	0.000596	0.000596	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—ISYNA1—salivary gland cancer	0.000591	0.000591	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—NUP62—salivary gland cancer	0.000591	0.000591	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—HRAS—salivary gland cancer	0.000588	0.000588	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—VCAN—salivary gland cancer	0.000586	0.000586	CbGpPWpGaD
Dapagliflozin—ABCB1—Transmembrane transport of small molecules—NUP62—salivary gland cancer	0.000578	0.000578	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—AQP1—salivary gland cancer	0.000574	0.000574	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—PTEN—salivary gland cancer	0.000572	0.000572	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—PTEN—salivary gland cancer	0.000572	0.000572	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—salivary gland cancer	0.000565	0.000565	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—EP300—salivary gland cancer	0.000546	0.000546	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—EP300—salivary gland cancer	0.000546	0.000546	CbGpPWpGaD
Dapagliflozin—SLC5A4—Metabolism—PIK3CA—salivary gland cancer	0.000533	0.000533	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—MARCKS—salivary gland cancer	0.000516	0.000516	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	0.000514	0.000514	CbGpPWpGaD
Dapagliflozin—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—salivary gland cancer	0.000505	0.000505	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—ISYNA1—salivary gland cancer	0.000505	0.000505	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—PHGDH—salivary gland cancer	0.000489	0.000489	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—MARCKS—salivary gland cancer	0.000486	0.000486	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—PIK3CA—salivary gland cancer	0.000482	0.000482	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—PIK3CA—salivary gland cancer	0.000482	0.000482	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—MARCKS—salivary gland cancer	0.000482	0.000482	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—PYGB—salivary gland cancer	0.000479	0.000479	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—ST3GAL4—salivary gland cancer	0.000471	0.000471	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—NUP62—salivary gland cancer	0.000455	0.000455	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—PYGB—salivary gland cancer	0.000452	0.000452	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—VCAN—salivary gland cancer	0.000452	0.000452	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—PYGB—salivary gland cancer	0.000448	0.000448	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—HRAS—salivary gland cancer	0.000446	0.000446	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—HRAS—salivary gland cancer	0.000446	0.000446	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—PTEN—salivary gland cancer	0.000442	0.000442	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—AQP1—salivary gland cancer	0.000428	0.000428	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—EP300—salivary gland cancer	0.000421	0.000421	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—salivary gland cancer	0.000418	0.000418	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—MARCKS—salivary gland cancer	0.000412	0.000412	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—PIK3CA—salivary gland cancer	0.000404	0.000404	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—PIK3CA—salivary gland cancer	0.000404	0.000404	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—salivary gland cancer	0.000403	0.000403	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—PHGDH—salivary gland cancer	0.000391	0.000391	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—ISYNA1—salivary gland cancer	0.00039	0.00039	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—salivary gland cancer	0.000385	0.000385	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—PYGB—salivary gland cancer	0.000383	0.000383	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—ST3GAL4—salivary gland cancer	0.000376	0.000376	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—PHGDH—salivary gland cancer	0.000368	0.000368	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	0.000367	0.000367	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—PHGDH—salivary gland cancer	0.000365	0.000365	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—ST3GAL4—salivary gland cancer	0.000355	0.000355	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—ST3GAL4—salivary gland cancer	0.000351	0.000351	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	0.00035	0.00035	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—AQP1—salivary gland cancer	0.000342	0.000342	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—NUP62—salivary gland cancer	0.000339	0.000339	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—VCAN—salivary gland cancer	0.000336	0.000336	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—AQP1—salivary gland cancer	0.000322	0.000322	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—AQP1—salivary gland cancer	0.000319	0.000319	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—MARCKS—salivary gland cancer	0.000318	0.000318	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—PHGDH—salivary gland cancer	0.000312	0.000312	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—PIK3CA—salivary gland cancer	0.000312	0.000312	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—ST3GAL4—salivary gland cancer	0.0003	0.0003	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—PYGB—salivary gland cancer	0.000295	0.000295	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	0.000295	0.000295	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—salivary gland cancer	0.000285	0.000285	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—CREBBP—salivary gland cancer	0.000282	0.000282	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—salivary gland cancer	0.000275	0.000275	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—AQP1—salivary gland cancer	0.000273	0.000273	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—NUP62—salivary gland cancer	0.000271	0.000271	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—VCAN—salivary gland cancer	0.000269	0.000269	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	0.000259	0.000259	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—NUP62—salivary gland cancer	0.000255	0.000255	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—VCAN—salivary gland cancer	0.000253	0.000253	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—NUP62—salivary gland cancer	0.000253	0.000253	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—VCAN—salivary gland cancer	0.000251	0.000251	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—PHGDH—salivary gland cancer	0.000241	0.000241	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—ST3GAL4—salivary gland cancer	0.000232	0.000232	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—CREBBP—salivary gland cancer	0.000229	0.000229	CbGpPWpGaD
Dapagliflozin—ABCB1—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	0.000224	0.000224	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	0.00022	0.00022	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—NUP62—salivary gland cancer	0.000216	0.000216	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—VCAN—salivary gland cancer	0.000215	0.000215	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	0.000211	0.000211	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—AQP1—salivary gland cancer	0.00021	0.00021	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—PTEN—salivary gland cancer	0.000201	0.000201	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	0.000201	0.000201	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—EP300—salivary gland cancer	0.000192	0.000192	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	0.000188	0.000188	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—CREBBP—salivary gland cancer	0.000177	0.000177	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—NUP62—salivary gland cancer	0.000167	0.000167	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—VCAN—salivary gland cancer	0.000166	0.000166	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—PTEN—salivary gland cancer	0.000164	0.000164	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	0.000157	0.000157	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—EP300—salivary gland cancer	0.000156	0.000156	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	0.00015	0.00015	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	0.000149	0.000149	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—PIK3CA—salivary gland cancer	0.000142	0.000142	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	0.000134	0.000134	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—CREBBP—salivary gland cancer	0.000132	0.000132	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	0.000128	0.000128	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—PTEN—salivary gland cancer	0.000126	0.000126	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—EP300—salivary gland cancer	0.00012	0.00012	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—PIK3CA—salivary gland cancer	0.000115	0.000115	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	0.000111	0.000111	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—CREBBP—salivary gland cancer	0.000105	0.000105	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—CREBBP—salivary gland cancer	9.9e-05	9.9e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—CREBBP—salivary gland cancer	9.81e-05	9.81e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	9.49e-05	9.49e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—PTEN—salivary gland cancer	9.39e-05	9.39e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—EP300—salivary gland cancer	8.96e-05	8.96e-05	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—PIK3CA—salivary gland cancer	8.89e-05	8.89e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—CREBBP—salivary gland cancer	8.39e-05	8.39e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—PTEN—salivary gland cancer	7.5e-05	7.5e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—EP300—salivary gland cancer	7.15e-05	7.15e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—PTEN—salivary gland cancer	7.07e-05	7.07e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—PTEN—salivary gland cancer	7.01e-05	7.01e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—EP300—salivary gland cancer	6.74e-05	6.74e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—EP300—salivary gland cancer	6.68e-05	6.68e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—PIK3CA—salivary gland cancer	6.63e-05	6.63e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—CREBBP—salivary gland cancer	6.47e-05	6.47e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—PTEN—salivary gland cancer	5.99e-05	5.99e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—EP300—salivary gland cancer	5.71e-05	5.71e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—PIK3CA—salivary gland cancer	5.29e-05	5.29e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—PIK3CA—salivary gland cancer	4.99e-05	4.99e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—PIK3CA—salivary gland cancer	4.94e-05	4.94e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—PTEN—salivary gland cancer	4.62e-05	4.62e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—EP300—salivary gland cancer	4.41e-05	4.41e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—PIK3CA—salivary gland cancer	4.22e-05	4.22e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—PIK3CA—salivary gland cancer	3.26e-05	3.26e-05	CbGpPWpGaD
